VaxGen AIDSVAX Hopes Hinge On Positive Finding In Small Subgroups
Executive Summary
VaxGen is pinning its hopes for the continued development of AIDSVAX on a positive finding in a small subgroup of black and Asian HIV patients after disappointing Phase III efficacy results in the general high-risk HIV population